This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Emerson, S. U.
Right arrow Articles by Purcell, R. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Emerson, S. U.
Right arrow Articles by Purcell, R. H.

 Previous Article  |  Next Article 

Journal of Virology, November 2006, p. 10457-10464, Vol. 80, No. 21
0022-538X/06/$08.00+0     doi:10.1128/JVI.00892-06

ORF3 Protein of Hepatitis E Virus Is Not Required for Replication, Virion Assembly, or Infection of Hepatoma Cells In Vitro{triangledown}

Suzanne U. Emerson,* Hanh Nguyen, Udana Torian, and Robert H. Purcell

Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892

Received 2 May 2006/ Accepted 15 August 2006

A subclone of Huh-7 cells that could be relatively efficiently transfected and infected with hepatitis E virus was identified. Following transfection, infectious virus was produced but remained predominantly cell associated. Intracellular virus, recovered by lysis of transfected cells, infected naïve cells. This in vitro-produced virus appeared to be antigenically identical to virus isolated from clinical samples. Lysates from cells transfected with mutant viral genomes unable to synthesize ORF3 protein contained infectious virions that were similar in number, thermostability, and sedimentation characteristics to those in lysates transfected with wild-type viral genomes. Therefore, in contrast to its requirement in vivo, ORF3 protein is not required for infection of Huh-7 cells or production of infectious virus in vitro.


* Corresponding author. Mailing address: Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Building 50, Room 6537, 50 South Drive, MSC 8009, Bethesda, MD 20892. Phone: (301) 496-2787. Fax: (301) 402-0524. E-mail: semerson{at}niaid.nih.gov.

{triangledown} Published ahead of print on 23 August 2006.


Journal of Virology, November 2006, p. 10457-10464, Vol. 80, No. 21
0022-538X/06/$08.00+0     doi:10.1128/JVI.00892-06




This article has been cited by other articles:

  • Yamada, K., Takahashi, M., Hoshino, Y., Takahashi, H., Ichiyama, K., Nagashima, S., Tanaka, T., Okamoto, H. (2009). ORF3 protein of hepatitis E virus is essential for virion release from infected cells. J. Gen. Virol. 90: 1880-1891 [Abstract] [Full Text]  
  • Pudupakam, R. S., Huang, Y. W., Opriessnig, T., Halbur, P. G., Pierson, F. W., Meng, X. J. (2009). Deletions of the Hypervariable Region (HVR) in Open Reading Frame 1 of Hepatitis E Virus Do Not Abolish Virus Infectivity: Evidence for Attenuation of HVR Deletion Mutants In Vivo. J. Virol. 83: 384-395 [Abstract] [Full Text]  
  • Billam, P., Pierson, F. W., Li, W., LeRoith, T., Duncan, R. B., Meng, X. J. (2008). Development and Validation of a Negative-Strand-Specific Reverse Transcription-PCR Assay for Detection of a Chicken Strain of Hepatitis E Virus: Identification of Nonliver Replication Sites. J. Clin. Microbiol. 46: 2630-2634 [Abstract] [Full Text]  
  • Chandra, V., Kar-Roy, A., Kumari, S., Mayor, S., Jameel, S. (2008). The Hepatitis E Virus ORF3 Protein Modulates Epidermal Growth Factor Receptor Trafficking, STAT3 Translocation, and the Acute-Phase Response. J. Virol. 82: 7100-7110 [Abstract] [Full Text]  
  • Graff, J., Zhou, Y.-H., Torian, U., Nguyen, H., St. Claire, M., Yu, C., Purcell, R. H., Emerson, S. U. (2008). Mutations within Potential Glycosylation Sites in the Capsid Protein of Hepatitis E Virus Prevent the Formation of Infectious Virus Particles. J. Virol. 82: 1185-1194 [Abstract] [Full Text]  
  • Moin, S. M., Panteva, M., Jameel, S. (2007). The Hepatitis E Virus Orf3 Protein Protects Cells from Mitochondrial Depolarization and Death. J. Biol. Chem. 282: 21124-21133 [Abstract] [Full Text]  
  • Huang, Y. W., Opriessnig, T., Halbur, P. G., Meng, X. J. (2007). Initiation at the Third In-Frame AUG Codon of Open Reading Frame 3 of the Hepatitis E Virus Is Essential for Viral Infectivity In Vivo. J. Virol. 81: 3018-3026 [Abstract] [Full Text]